Organometallics
Article
4F), −167.4 (mc, 8F). 31P{1H} NMR (202 MHz, CD2Cl2): δ/ppm
silica gel (eluent: n-pentane) afforded 15 (5.0 mg, 14 μmol, 12%, 0%
123.2 (d, JP,F = 1060 Hz). The crystallographic data are available
ee) as a colorless liquid. IR (ATR): ν
̃
/cm−1 2137, 1428, 1366, 1268,
1
online in the CCDC database under number CCDC 1882910.
Triethyl(2,2,2-trifluoro-1-phenylethoxy)silane (12). Prepared
according to GP1 from 2,2,2-trifluoro-1-phenylethan-1-one (11, 30
mg, 0.17 mmol, 1.0 equiv), Et3SiH (24 mg, 0.21 mmol, 1.2 equiv),
and (S)-6 (2.0 mg, 1.7 μmol, 1.0 mol %) in CD2Cl2 (0.6 mL) within a
reaction time of 6 h. Purification of the crude product on silica gel
(eluent: n-pentane) afforded 12 (39 mg, 0.13 mmol, 73%, 0% ee) as a
1206, 1170, 1121, 1070, 1028, 849, 809, 733, 695. HRMS (EI):
calculated for C8H7F3O+ [(M + H − C12H11Si)+]: 176.0444; found:
176.0434. HRMS (EI): calculated for C12H11Si• [(M − C8H7F3O)•]:
1
183.0630; found: 183.0622. H NMR (500 MHz, CD2Cl2): δ/ppm
5.04 (q, 3JH,F = 6.7 Hz, 1H), 5.42 (s, 1H), 7.34−7.51 (m, 11H), 7.53−
7.57 (m, 2H), 7.58−7.62 (m, 2H). 13C{1H} NMR (126 MHz,
CD2Cl2): δ/ppm 75.0 (q, 2JC,F = 32.7 Hz), 124.6 (q, 1JC,F = 285 Hz),
128.2 (s, 2C), 128.5 (s, 2C), 128.6 (s, 2C), 128.8 (s, 2C), 129.8 (s),
131.2 (s), 131.3 (s), 132.67 (s), 132.71 (s), 134.5 (s), 135.0 (s, 2C),
135.1 (s, 2C). 19F{1H} NMR (471 MHz, CD2Cl2): δ/ppm = −78.3
(s). 1H/29Si HMQC (500/99 MHz, CD2Cl2, optimized for J = 7 Hz):
δ/ppm 5.04/−8.1, 5.42/−8.1, (7.53−7.57)/−8.1, (7.58−7.62)/−8.1.
The enantiomeric excess was determined by HPLC analysis on a
chiral stationary phase (Daicel Chiracel OJ-RH column, column
temperature 20 °C, solvent MeCN/H2O 50/50, flow rate 0.4 mL/
min, λ 210 nm): tR,1 = 46.9 min, tR,2 = 80.1 min.
colorless liquid. IR (ATR): ν/
̃
cm−1 2957, 2879, 1456, 1365, 1269,
1240, 1205, 1166, 1126, 1072, 1004, 974, 853, 830, 728, 697, 671.
HRMS (EI): calculated for C12H16F3OSi+ [(M − C2H5)+]: 261.0917;
1
found: 261.0923. H NMR (500 MHz, CD2Cl2): δ/ppm 0.55−0.66
3
3
(m, 6H), 0.90 (t, JH,H = 7.9 Hz, 9H), 4.97 (q, JH,F = 6.7 Hz, 1H),
7.37−7.42 (m, 3H), 7.44−7.79 (m, 2H). 13C{1H} NMR (126 MHz,
CD2Cl2): δ/ppm 4.8 (s, 3C), 6.6 (s, 3C), 73.7 (q, JC,F = 31.8 Hz),
2
1
124.8 (q, JC,F = 284 Hz), 128.0 (s, 2C), 128.7 (s, 2C), 129.5 (s),
136.1 (s). 19F{1H} NMR (471 MHz, CD2Cl2): δ/ppm −78.7 (s).
1H/29Si HMQC (500/99 MHz, CD2Cl2, optimized for J = 7 Hz): δ/
ppm 0.55−0.66/24.4, 0.90/24.4. The enantiomeric excess was
determined by HPLC analysis on a chiral stationary phase (Daicel
Chiracel OJ-RH column, column temperature 20 °C, solvent MeCN/
2,2,2-Trifluoro-1-phenylethanol (16). Prepared according to
GP1 from 2,2,2-trifluoro-1-phenylethan-1-one (11, 20 mg, 0.12
mmol, 1.0 equiv), PhSiH3 (14 mg, 0.13 mmol, 1.1 equiv), and (S)-
5 (1.4 mg, 1.1 μmol, 1.0 mol %) in CD2Cl2 (0.6 mL) within a reaction
time of 24 h. Purification of the crude product on silica gel (eluent: n-
pentane/tert-butyl methyl ether 100/0 → 6/1) afforded 16 (12 mg,
H2O 50/50, flow rate 0.4 mL/min, λ 210 nm): tR,1 = 59.7 min, tR,2
=
65.2 min. The analytical data are in accordance with those reported.4
(2,2,2-Trifluoro-1-phenylethoxy)dimethyl(phenyl)silane
(13). Prepared according to GP1 from 2,2,2-trifluoro-1-phenylethan-
1-one (11, 20 mg, 0.12 mmol, 1.0 equiv), Me2PhSiH (18 mg, 0.13
mmol, 1.1 equiv), and (S)-5 (1.4 mg, 1.1 μmol, 1.0 mol %) in CD2Cl2
(0.6 mL) within a reaction time of 4 h. Purification of the crude
product on silica gel (eluent: n-pentane) afforded 13 (34 mg, 0.11
68 μmol, 57%, 0% ee) as a yellowish liquid. IR (ATR): ν
̃
/cm−1 3403,
1456, 1429, 1356, 1262, 1165, 1121, 1058, 922, 865, 832, 758, 700.
HRMS (EI): calculated for C8H7F3O+ [M+]: 176.0444; found:
176.0445. 1H NMR (500 MHz, CD2Cl2): δ/ppm 2.75 (d, 3JH,H = 4.7
Hz, 1H), 5.06 (mc, 1H), 7.41−7.45 (m, 3H), 7.45−7.51 (m, 2H).
13C{1H} NMR (126 MHz, CD2Cl2): δ/ppm 72.9 (q, 2JC,F = 34.4 Hz),
1
mmol, 95%, 0% ee) as a colorless liquid. IR (ATR): ν
̃
124.8 (q, JC,F = 285 Hz), 127.8 (s, 2C), 129.0 (s, 2C), 129.9 (s),
1428, 1367, 1267, 1206, 1167, 1117, 1072, 1029, 999, 860, 828, 786,
738, 697. HRMS (EI): calculated for C16H17F3OSi+ [M+]: 310.0995;
found: 310.0981. 1H NMR (500 MHz, CD2Cl2): δ/ppm 0.33 (s, 3H),
0.38 (s, 3H), 4.90 (q, 3JH,F = 6.7 Hz, 1H), 7.32−7.43 (m, 8H), 7.49−
7.53 (m, 2H). 13C{1H} NMR (126 MHz, CD2Cl2): δ/ppm −1.5 (s),
−1.4 (s), 73.8 (q, 2JC,F = 32.6 Hz), 124.7 (q, 1JC,F = 281 Hz), 128.1 (s,
2C), 128.3 (s, 2C), 128.7 (s, 2C), 129.6 (s), 130.4 (s), 133.9 (s, 2C),
135.5 (s), 136.4 (s). 19F{1H} NMR (471 MHz, CD2Cl2): δ/ppm
−78.6 (s). 29Si{1H} DEPT (99 MHz, CD2Cl2, optimized for J = 7
Hz): δ/ppm 13.1 (s). The enantiomeric excess was determined by
HPLC analysis on a chiral stationary phase (Daicel Chiracel OJ-H
column, column temperature 20 °C, solvent n-heptane/i-PrOH 95/5,
flow rate 0.8 mL/min, λ 210 nm): tR,1 = 6.2 min, tR,2 = 8.2 min.
(2,2,2-Trifluoro-1-phenylethoxy)methyl(diphenyl)silane
(14). Prepared according to GP1 from 2,2,2-trifluoro-1-phenylethan-
1-one (11, 20 mg, 0.12 mmol, 1.0 equiv), MePh2SiH (25 mg, 0.13
mmol, 1.1 equiv), and (S)-5 (1.4 mg, 1.1 μmol, 1.0 mol %) in CD2Cl2
(0.6 mL) with a reaction time of 2 h. Purification of the crude product
on silica gel (eluent: n-pentane) afforded 14 (22 mg, 0.059 mmol,
134.6 (s). 19F{1H} NMR (471 MHz, CD2Cl2): δ/ppm = −78.7 (s).
The enantiomeric excess was determined by HPLC analysis on a
chiral stationary phase (Daicel Chiracel AD-H column, column
temperature 20 °C, solvent n-heptane/i-PrOH 98/2, flow rate 0.8
mL/min, λ 210 nm): tR,1 = 22.5 min, tR,2 = 24.1 min. The analytical
data are in accordance with those reported.37
(1-Cyclohexylethoxy)triethylsilane (22). Prepared according to
GP1 from 1-cyclohexylethan-1-one (17, 15 mg, 0.12 mmol, 1.0
equiv), Et3SiH (29 mg, 0.25 mmol, 2.1 equiv), and (S)-5 (1.4 mg, 12
μmol, 1.0 mol %) in CD2Cl2 (0.6 mL) within a reaction time of 1 h.
Purification of the crude product on silica gel (eluent: n-pentane)
afforded 22 (>95% conversion, 0% ee) in a mixture with disiloxane as
a colorless liquid. IR (ATR): ν/
̃
cm−1 2923, 2875, 1450, 1413, 1372,
1298, 1236, 1188, 1139, 1069, 1003, 967, 910, 840, 775, 722, 672.
HRMS (APCI): calculated for C14H31OSi+ [(M + H)+]: 243.2139;
1
found: 243.2140. H NMR (400 MHz, CD2Cl2): δ/ppm 0.58 (q,
3
3JH,H = 7.8 Hz, 6H), 0.89−0.98 (m, 11H), 1.07 (d, JH,H = 6.6 Hz,
3
3H), 1.11−1.27 (m, 4H), 1.59−1.83 (m, 5H), 3.55 (qd, JH,H = 6.1
Hz, 3JH,H = 6.1 Hz, 1H). 13C{1H} NMR (126 MHz, CD2Cl2): δ/ppm
5.4 (s, 3C), 7.1 (s, 3C), 21.0 (s), 26.86 (s), 26.88 (s), 27.2 (s), 29.1
(s), 29.2 (s), 46.2 (s), 72.9 (s). 1H/29Si HMQC (500/99 MHz,
CD2Cl2, optimized for J = 7 Hz): δ/ppm (0.55−0.62)/15.5, (0.89−
0.98)/15.5, 3.55/15.5. The enantiomeric excess was determined by
HPLC analysis of the corresponding 4-nitrobenzoyl ester38 on a chiral
stationary phase (Daicel Chiracel AD-H column, column temperature
20 °C, solvent n-heptane/i-PrOH 100/0, flow rate 0.8 mL/min, λ 210
nm): tR,1 = 35.2 min, tR,2 = 37.6 min. The analytical data are in
accordance with those reported.7
51%, 0% ee) as a colorless liquid. IR (ATR): ν
̃
/cm−1 3048, 1454,
1428, 1366, 1267, 1206, 1168, 1115, 1072, 1029, 998, 843, 791, 725,
696, 663. HRMS (EI): calculated for C21H19F3OSi+ [M+]: 372.1152;
found: 372.1140. 1H NMR (500 MHz, CD2Cl2): δ/ppm 0.61 (s, 3H),
3
5.00 (q, JH,F = 6.7 Hz, 1H), 7.35−7.49 (m, 11H), 7.54−7.59 (m,
4H). 13C{1H} NMR (126 MHz, CD2Cl2): δ/ppm −2.7 (s), 73.6 (q,
1
2JC,F = 32.9 Hz), 124.8 (q, JC,F = 281 Hz), 128.2 (s, 2C), 128.3 (s,
2C), 128.4 (s, 2C), 128.7 (s, 2C), 129.7 (s), 130.6 (s), 130.7 (s),
134.7 (s, 2C), 134.8 (s, 2C), 134.9 (s), 135.1 (s), 135.3 (s). 19F{1H}
NMR (471 MHz, CD2Cl2): δ/ppm −78.3 (s). 1H/29Si HMQC (500/
99 MHz, CD2Cl2, optimized for J = 7 Hz): δ/ppm 0.61/1.8, 5.00/1.8.
The enantiomeric excess was determined by HPLC analysis on a
chiral stationary phase (Daicel Chiracel OJ-RH column, column
temperature 20 °C, solvent MeCN/H2O 60/40, flow rate 0.4 mL/
min, λ 210 nm): tR,1 = 36.3 min, tR,2 = 41.7 min.
(2,2,2-Trifluoro-1-phenylethoxy)diphenylsilane (15). Pre-
pared according to GP1 from 2,2,2-trifluoro-1-phenylethan-1-one
(11, 20 mg, 0.12 mmol, 1.0 equiv), Ph2SiH2 (23 mg, 0.13 mmol, 1.1
equiv), and (S)-5 (1.4 mg, 1.1 μmol, 1.0 mol %) in CD2Cl2 (0.6 mL)
within a reaction time of 2 h. Purification of the crude product on
Dimethyl[(4-methylpentan-2-yl)oxy](phenyl)silane (23).
Prepared according to GP1 from isobutyl methyl ketone (18, 15
mg, 0.15 mmol, 1.0 equiv), Me2PhSiH (28 mg, 0.21 mmol, 1.4 equiv),
and (S)-5 (1.8 mg, 15 μmol, 1.0 mol %) in CD2Cl2 (0.6 mL) within a
reaction time of 19 h. Purification of the crude product on silica gel
(eluent: n-pentane) afforded 23 (>95% conversion, 0% ee) as a
colorless liquid. HRMS (APCI): calculated for C13H21OSi+ [(M −
1
CH3)+]: 221.1362; found: 220.9857 (no better value obtained). H
NMR (500 MHz, CD2Cl2): δ/ppm 0.33 (mc, 6H), 0.90 (mc, 3H),
3
0.91 (mc, 3H), 1.15 (d, JH,H = 6.1 Hz, 3H), 1.17−1.24 (m, 1H),
1.33−1.40 (m, 1H), 1.67−1.76 (m, 1H), 3.80−3.88 (m, 1H), 7.32−
G
Organometallics XXXX, XXX, XXX−XXX